Difference between revisions of "Genentech"

From SourceWatch
Jump to navigation Jump to search
m (SW: fix grammar)
(SW: add internal links, update corporate info, add categories.)
Line 15: Line 15:
 
===Facility information, progress reports & USDA-APHIS reports===
 
===Facility information, progress reports & USDA-APHIS reports===
 
For copies of this facility's [[U.S. Department of Agriculture]]-Animal Plant Health Inspection (APHIS) reports, other information and links, see also [http://www.all-creatures.org/saen/res-fr.html Stop Animal Experimentation Now!: Facility Reports and Information]. This site lists each of the 50 states; each state's name links to biomedical research facilities in that state and to PDF copies of government documents where the facilities must report their animal usage.
 
For copies of this facility's [[U.S. Department of Agriculture]]-Animal Plant Health Inspection (APHIS) reports, other information and links, see also [http://www.all-creatures.org/saen/res-fr.html Stop Animal Experimentation Now!: Facility Reports and Information]. This site lists each of the 50 states; each state's name links to biomedical research facilities in that state and to PDF copies of government documents where the facilities must report their animal usage.
 +
 +
==Clinical trials== 
 +
 +
===Toxic drug trials on foster children===
 +
See also [[foster child drug trials]].
  
 
==Selected staff & board==
 
==Selected staff & board==
  
−
* Ian Clark - CEO
+
* [[Arthur Levinson]] - Chairman
−
* Pascal Soriot - CEO
+
* [[Ian Clark]] - CEO
−
* Steve Krognes - CFO <ref>[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Hoovers, accessed December 2009</ref>
+
* [[Steve Krognes]] - CFO <ref>[http://www.hoovers.com/genentech/--ID__10628--/free-co-factsheet.xhtml Company Description: Genentech], Hoovers, accessed March 2010</ref>
 
* [[Laura A. Leber]]
 
* [[Laura A. Leber]]
−
* [[J. Richard Munro]] - CEO (ret.) <ref>[http://www.pointsoflight.org/about/directors.cfm Board of Directors], Points of Light Foundation, accessed July 2007</ref>
+
* [[Amo Houghton]]
−
* [[William D. Young]] - Former COO - <ref>[http://www.biogenidec.com/site/030.html Board of Directors], [[Biogen Idec]], accessed July 2007</ref>
+
 
−
*[[Amo Houghton]]
+
===Former staff===
 +
* [[J. Richard Munro]] - CEO <ref>[http://www.pointsoflight.org/about/directors.cfm Board of Directors], [[Points of Light Foundation]], accessed July 2007</ref>
 +
* [[William D. Young]] - COO <ref>[http://www.biogenidec.com/site/030.html Board of Directors], [[Biogen Idec]], accessed July 2007</ref>
  
 
===Board===
 
===Board===
−
* [[Herbert W. Boyer]], Ph.D., Vice-Chairman of the Board - [[Allergan]], Inc.
+
* [[Herbert W. Boyer]], PhD, Vice-Chairman of the Board - [[Allergan]], Inc.
 
* [[William M. Burns]]
 
* [[William M. Burns]]
 
* [[Erich Hunziker]]
 
* [[Erich Hunziker]]
−
*[[Jonathan K.C. Knowles]], Ph.D.
+
* [[Jonathan K.C. Knowles]], PhD
−
*[[Arthur D. Levinson]], Ph.D.  - Board - [[Apple Computer]], Inc.
+
* [[Arthur D. Levinson]], PhD - Board - [[Apple Computer]], Inc.
−
*[[Debra L. Reed]] - Board - [[Halliburton Company]]
+
* [[Debra L. Reed]] - Board - [[Halliburton Company]]
−
*[[Charles  A. Sanders]], M.D. <ref>[http://www.gene.com/gene/about/management/board_of_directors.html Board of Directors], Genentech, accessed July 2007</ref>
+
* [[Charles  A. Sanders]], MD <ref>[http://www.gene.com/gene/about/management/board_of_directors.html Board of Directors], Genentech, accessed July 2007</ref>
  
 
==Executive compensation (2007)==
 
==Executive compensation (2007)==
Line 45: Line 52:
 
==Political Contributions==
 
==Political Contributions==
  
−
Genentech gave almost $400,000 to candidates in the 2008 election cycle through its [[political action committee]].<ref>[http://www.campaignmoney.com/political/committees/genentech-inc-political-action-committee-genenpac.asp?cycle=08], "CampaignMoney.com," accessed on November 15, 2009.</ref> This is almost twice as much as in 2006, when it donated $201,500 to federal candidates in the 2006 election through its [[political action committee]] - 38% to [[Democrats]] and 57% to [[Republican Party (USA)|Republicans]].<ref>[http://www.opensecrets.org/pacs/lookup2.asp?strid=C00199257&cycle=2006 2006 PAC Summary Data], ''Open Secrets'', accessed December 2007.</ref>
+
Genentech gave almost $400,000 to candidates in the 2008 election cycle through its [[political action committee]] (PAC).<ref>[http://www.campaignmoney.com/political/committees/genentech-inc-political-action-committee-genenpac.asp?cycle=08 Genentech, Inc. Political Action Committee], CampaignMoney.com, accessed March 2010</ref>
 +
 
 +
This is almost twice as much as in 2006, when it donated $201,500 to federal candidates.  - 38% to [[Democrats]] and 57% to [[Republican Party (USA)|Republicans]].<ref>[http://www.opensecrets.org/pacs/lookup2.asp?strid=C00199257&cycle=2006 2006 PAC Summary Data], ''Open Secrets'', accessed December 2007.</ref>
  
 
==Lobbying==
 
==Lobbying==
  
−
According to [[Lisa Graves]] of the [[Center for Media and Democracy]] a search of the Lobby Disclosure Act database for "Genentech" spending in 2009 reveals that the company spent over $3.7 million in lobbying Congress on health care issues in the first three quarters on the year, including over $2.1 million itself and the remainder on lobbyists such as the [[American Continental Group]].<ref>[[Lisa Graves]] ''Biotech's Ghostwriting Animates Congressional Speeches on Health Reform'', [[Center for Media and Democracy]], November 15, 2009.</ref> Genentech's lobbying made the news after its talking points showed up in the statements that several Members of Congress submitted to the Congressional Record, the official journal of congressional proceedings, during the 2009 debate over health care reforms. <ref>Robert Pear [http://www.nytimes.com/2009/11/15/us/politics/15health.html?pagewanted=2&_r=1&adxnnl=1&ref=politics&adxnnlx=1258294232-7WmWloVRzvQfa4/As1ohkQ In House, Many Spoke with One Voice: Lobbyists], [[New York Times]], November 2009</ref>
+
According to [[Lisa Graves]] of the [[Center for Media and Democracy]], a search of the 2009 ''Lobby Disclosure Act'' database for Genentech, revealed that the company spent over $3.7 million [[lobbying]] [[Congress]] on [[health care]] issues in the first three quarters on the year.  The company spent over $2.1 million dollars on in-house lobbyists with the remainder going to outside firms such as the [[American Continental Group]].<ref>[[Lisa Graves]] ''Biotech's Ghostwriting Animates Congressional Speeches on Health Reform'', [[Center for Media and Democracy]], November 15, 2009.</ref>
 +
 
 +
Genetech's lobbying made the news after its talking points showed up in the statements submitted by several members of Congress to the Congressional Record (the official journal of congressional proceedings), during the 2009 health care reform debate. <ref>Robert Pear [http://www.nytimes.com/2009/11/15/us/politics/15health.html?pagewanted=2&_r=1&adxnnl=1&ref=politics&adxnnlx=1258294232-7WmWloVRzvQfa4/As1ohkQ In House, Many Spoke with One Voice: Lobbyists], [[New York Times]], November 2009</ref>
  
 
==Contact==
 
==Contact==
Line 66: Line 77:
  
 
===Sourcewatch articles===
 
===Sourcewatch articles===
 +
* [[AIDS industry]]
 
* [[Animal testing]]
 
* [[Animal testing]]
 
* [[Biotechnology]]
 
* [[Biotechnology]]
 +
* [[Foster child drug trials]]
 +
* [[HIV/AIDS]]
 
* [[Pharmaceutical industry]]
 
* [[Pharmaceutical industry]]
 
* [[Roche]]
 
* [[Roche]]
Line 75: Line 89:
 
{{reflist|2}}
 
{{reflist|2}}
  
−
[[category: Global corporations]] [[Category: Pharmaceutical industry]][[category: International]] [[Category: Animal testing]] [[Category: Cancer]]
+
[[Category: Global corporations]] [[Category: Pharmaceutical industry]][[category: International]] [[Category: Animal testing]] [[Category: Cancer]] [[Category: AIDS]] [[Category: Human rights abuses]]

Revision as of 17:54, 25 March 2010

{{#badges: GlobalCorpWiki}}

Genentech, Inc. is a pharmaceutical company and one of the world's most financially successful and biotechnology corporations. The Swiss drug company Roche, which previously owned a majority of stock in the San Francisco based firm, took full ownership in 2009. Genentech has three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin's lymphoma; Avastin, for colorectal, non-small cell lung cancers, and treats macular degeneration; and Herceptin for breast cancer. It also manufactures the lung cancer drug Tarceva. Major customers for its drugs are AmerisourceBergen, Cardinal Health, and McKesson. In the fiscal year ending in December of 2008, Genentech had sales of 13.4 billion dollars and had 11,174 employees. [1]

According to its website, the company is "considered the founder of the biotechnology industry." The company has "been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, commercialize and manufacture biotherapeutics that address significant unmet medical needs." [2]

Animal testing

Genentech does animal testing.

Animals by species, numbers & location

  • San Francisco, California [3]

Facility information, progress reports & USDA-APHIS reports

For copies of this facility's U.S. Department of Agriculture-Animal Plant Health Inspection (APHIS) reports, other information and links, see also Stop Animal Experimentation Now!: Facility Reports and Information. This site lists each of the 50 states; each state's name links to biomedical research facilities in that state and to PDF copies of government documents where the facilities must report their animal usage.

Clinical trials

Toxic drug trials on foster children

See also foster child drug trials.

Selected staff & board

Former staff

Board

Executive compensation (2007)

Political Contributions

Genentech gave almost $400,000 to candidates in the 2008 election cycle through its political action committee (PAC).[13]

This is almost twice as much as in 2006, when it donated $201,500 to federal candidates. - 38% to Democrats and 57% to Republicans.[14]

Lobbying

According to Lisa Graves of the Center for Media and Democracy, a search of the 2009 Lobby Disclosure Act database for Genentech, revealed that the company spent over $3.7 million lobbying Congress on health care issues in the first three quarters on the year. The company spent over $2.1 million dollars on in-house lobbyists with the remainder going to outside firms such as the American Continental Group.[15]

Genetech's lobbying made the news after its talking points showed up in the statements submitted by several members of Congress to the Congressional Record (the official journal of congressional proceedings), during the 2009 health care reform debate. [16]

Contact

Genentech, Inc. 1 DNA Way
South San Francisco, CA 94080

Phone: 650-225-1000

Fax: 650-225-6000

Web address: http://www.gene.com

Articles & sources

Sourcewatch articles

References

  1. ↑ Company Description: Genentech, Hoovers, accessed December 2009
  2. ↑ About Us: Leading the Biotechnology Industry, Genentech, accessed July 2007
  3. ↑ Research Facilities: Genentech, Inc., San Francisco, California, Humane Society of the United States, accessed December 2009
  4. ↑ Company Description: Genentech, Hoovers, accessed March 2010
  5. ↑ Board of Directors, Points of Light Foundation, accessed July 2007
  6. ↑ Board of Directors, Biogen Idec, accessed July 2007
  7. ↑ Board of Directors, Genentech, accessed July 2007
  8. ↑ Arthur D Levinson, Forbes, accessed December 2007.
  9. ↑ Susan D Desmond-Hellmann, Forbes, accessed December 2007.
  10. ↑ David A Ebersman, Forbes, accessed December 2007.
  11. ↑ Stephen G Juelsgaard, Forbes, accessed December 2007.
  12. ↑ Richard H Scheller, Forbes, accessed December 2007
  13. ↑ Genentech, Inc. Political Action Committee, CampaignMoney.com, accessed March 2010
  14. ↑ 2006 PAC Summary Data, Open Secrets, accessed December 2007.
  15. ↑ Lisa Graves Biotech's Ghostwriting Animates Congressional Speeches on Health Reform, Center for Media and Democracy, November 15, 2009.
  16. ↑ Robert Pear In House, Many Spoke with One Voice: Lobbyists, New York Times, November 2009
Retrieved from "https://www.sourcewatch.org/index.php?title=Genentech&oldid=468946"